New drug targets in depression: Inflammatory, cell-mediate immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. and new drug candidates-Nrf2 activators and GSK-3 inhibitors
Version 2 2024-05-30, 15:38Version 2 2024-05-30, 15:38
Version 1 2014-10-28, 09:44Version 1 2014-10-28, 09:44
journal contribution
posted on 2024-05-30, 15:38authored byM Maes, Z Fišar, M Medina, G Scapagnini, G Nowak, Michael BerkMichael Berk
New drug targets in depression: Inflammatory, cell-mediate immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. and new drug candidates-Nrf2 activators and GSK-3 inhibitors